Cardiovascular MRI in thalassemia major

Area of Science:

• Cardiology
• Radiology
• Hematology

Background:

• Cardiac toxicity is a major concern for thalassemia major patients.
• Somatic iron stores do not fully predict cardiac risk.
• Early detection of cardiac iron is crucial for management.

Purpose of the Study:

• To review the impact of cardiac MRI T2* on thalassemia major patient care.
• To highlight the role of MRI in assessing myocardial iron and cardiac function.
• To discuss the transition of cardiac T2* from research to standard care.

Main Methods:

• Cardiac MRI T2* for preclinical recognition of myocardial iron.
• Assessment of cardiac function using MRI.
• Review of historical context and technical details of T2* imaging.

Main Results:

• Cardiac T2* allows preclinical recognition and risk stratification of myocardial iron.
• MRI assessment of cardiac function provides accurate ventricular assessments.
• Cardiac T2* tracks response to iron chelation therapy modifications.

Conclusions:

• Cardiac MRI T2* has revolutionized thalassemia major treatment.
• It enables early detection, risk stratification, and monitoring of iron cardiomyopathy.
• Cardiac T2* is becoming the standard of care for managing cardiac risk in these patients.